Akoya Biosciences (AKYA)
(Real Time Quote from BATS)
$2.79 USD
-0.11 (-3.79%)
Updated May 15, 2024 10:06 AM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.26 |
EPS Last Quarter | -0.35 |
Last EPS Surprise | -16.67% |
ABR | 1.28 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.86 |
Next Year | -0.50 |
EPS (TTM) | -1.34 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 27.08M | 29.50M | 115.48M | 137.73M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 28.70M | 30.40M | 116.28M | 140.40M |
Low Estimate | 23.50M | 28.50M | 115.00M | 134.60M |
Year ago Sales | 23.52M | 25.22M | 96.63M | 115.48M |
Year over Year Growth Est. | 15.14% | 16.97% | 19.50% | 19.27% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.26 | -0.19 | -0.86 | -0.50 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.26 | -0.20 | -0.87 | -0.51 |
High Estimate | -0.22 | -0.16 | -0.80 | -0.49 |
Low Estimate | -0.30 | -0.20 | -0.90 | -0.51 |
Year ago EPS | -0.51 | -0.26 | -1.43 | -0.86 |
Year over Year Growth Est. | 49.02% | 26.92% | 39.86% | 41.86% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.26 | -0.19 | -0.86 | -0.50 |
7 Days Ago | -0.26 | -0.19 | -0.86 | -0.50 |
30 Days Ago | -0.26 | -0.19 | -0.86 | -0.50 |
60 Days Ago | -0.25 | -0.18 | -0.86 | -0.50 |
90 Days Ago | -0.25 | -0.24 | -0.90 | -0.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.26 | -0.19 | -0.86 | -0.50 |
Zacks Consensus Estimate | -0.26 | -0.19 | -0.86 | -0.50 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.35 | -0.22 | -0.26 | -0.51 | NA |
Estimate | -0.30 | -0.27 | -0.37 | -0.44 | NA |
Difference | -0.05 | 0.05 | 0.11 | -0.07 | 0.01 |
Surprise | -16.67% | 18.52% | 29.73% | -15.91% | 3.92% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more